Avian Cholera (Fowl Cholera): Etiology, Pathogenesis, and Control

Introduction

Avian cholera, also termed fowl cholera, is a highly contagious bacterial disease of domestic and wild birds caused by Pasteurella multocida [1, 32]. This septicemic infection is recognized globally as a significant cause of morbidity and mortality in poultry, waterfowl, seabirds, and other avian species [2, 3]. The disease can manifest as peracute, acute, or chronic forms, with mortality rates often exceeding 40% in susceptible populations [4, 3]. Outbreaks of avian cholera have been documented across diverse ecosystems, from commercial poultry operations to remote Arctic and Antarctic seabird colonies [5, 34]. The economic and ecological impacts of this disease underscore the need for a detailed understanding of its etiology, pathogenesis, and control measures.

Etiology

The causal agent of fowl cholera bacterial disease is Pasteurella multocida, a Gram-negative, non-motile coccobacillus belonging to the family Pasteurellaceae [1, 32]. The bacterium is classified into five capsular serogroups (A, B, D, E, F) and 16 somatic lipopolysaccharide serotypes based on the Heddleston scheme [32]. In avian hosts, capsular serogroup A and somatic serotypes 1, 3, and 4 are most commonly isolated [2, 6, 1]. The type strain P-1059 (serotype A:3) has been extensively used in experimental pathogenesis studies [7].

P. multocida expresses a variety of virulence factors that facilitate colonization, immune evasion, and tissue damage. Filamentous hemagglutinins (FhaB1 and FhaB2) are large adhesins that contribute to attachment and biofilm formation [7]. While FhaB2 has been shown to be essential for virulence in turkeys, studies have demonstrated that FhaB1 is not required for the development of acute fowl cholera [7]. Capsular polysaccharide is a critical antiphagocytic factor; encapsulated strains typically cause acute disease, whereas capsule-deficient variants are associated with chronic infections or asymptomatic carriage [8]. Biofilm formation is another key determinant of chronic disease. Biofilm-proficient strains of P. multivocida produce extracellular polysaccharide matrix that protects bacteria from host defenses and antimicrobials, leading to persistent, low-grade infections [8].

Pathogenesis

Infection typically occurs via the respiratory or oral routes after exposure to contaminated fomites, water, or carcasses [9, 1]. Upon inhalation or ingestion, P. multocida adheres to mucosal epithelium of the upper respiratory tract and oropharynx [32]. The bacterium then invades the bloodstream, leading to rapid septicemia and endotoxemia [10, 11]. The lipopolysaccharide component of the outer membrane triggers a strong inflammatory response.

The host immune response to acute avian cholera is characterized by a mixed Th1/Th17 profile. In experimentally infected chickens, splenic expression of interferon-gamma (IFN-γ), interleukin-1β (IL-1β), IL-6, IL-12A, IL-22, IL-17A, and IL-17RA is markedly upregulated in birds that succumb to acute infection [8]. Neutrophil (heterophil) infiltration is prominent in the lungs, liver, and heart of birds with acute disease [8, 10]. In contrast, chronic infections are associated with biofilm formation and a more subdued inflammatory response, with minimal heterophil recruitment and lower cytokine levels [8]. Capsule-deficient strains that form robust biofilms can persist in tissues for weeks, causing chronic pneumonia and arthritis [8]. Biofilm matrix material and exopolysaccharide have been visualized in pulmonary tissues of chickens with chronic avian cholera using scanning electron microscopy and lectin staining [8].

Epidemiology

Avian cholera is enzootic in many regions and can cause explosive epornitics in wild bird populations [12, 1, 31]. Transmission occurs through direct contact with infected birds, ingestion of contaminated water or feed, and scavenging on infected carcasses [9, 1]. The bacterium can persist in aquatic environments for extended periods; P. multocida has been isolated from wetlands up to several weeks after an outbreak, indicating environmental reservoirs [33, 35].

Outbreaks are strongly influenced by climatic and ecological factors. In Guangxi, China, monthly mean temperature, relative humidity, rainfall, and the multivariate El Niño Southern Oscillation Index were significantly correlated with avian cholera incidence [13]. In the Arctic, outbreaks in Northern Common Eiders (Somateria mollissima borealis) have been linked to colony size, vegetation cover, and host crowding in shared wetlands [12]. The spatial clustering of outbreaks along migration corridors suggests that introduced foci can propagate through flyways [12]. Temperature inversions that cause stress are also reported triggers in captive canaries [4].

Host susceptibility varies across species. Waterfowl, especially eiders, scoters, and gulls, are highly susceptible, often suffering mass mortality [14, 15, 3]. Seabirds such as albatrosses, penguins, and petrels are also vulnerable [5, 2]. In the Bering Sea, avian cholera caused mortality in Crested Auklets and other marine birds [15]. The disease has been documented in penguin species, including Yellow-eyed Penguins (Megadyptes antipodes) in New Zealand and Adélie Penguins in Antarctica [14, 34]. In poultry, chickens, turkeys, pheasants, and canaries are susceptible [7, 4, 16].

Clinical Signs and Pathology

The clinical presentation of avian cholera depends on the acuteness of the infection. In peracute cases, birds are found dead with no premonitory signs, often in good body condition [4, 11]. Acute cases present with fever, depression, anorexia, ruffled feathers, dyspnea, cyanosis, mucoid diarrhea, and sudden death within 12 to 48 hours [4, 10]. Chronic infections are characterized by localized lesions: swollen joints (arthritis), sternal bursitis, conjunctivitis, torticollis, and wattles or comb swelling due to fibrinopurulent inflammation [8, 30].

Table 1. Common clinical signs and gross lesions in avian cholera.

Histopathological findings in acute disease include hepatic necrosis, fibrinoid necrosis of blood vessels, and intravascular bacterial emboli [10, 11]. In chronic cases, heterophil granulomas and biofilm aggregates are observed in joint spaces and periarticular tissues [8]. The severity of inflammation correlates with the capsule and biofilm status of the infecting strain [8].

Diagnostics

Definitive diagnosis of avian cholera requires isolation and identification of P. multivocida from affected tissues (liver, spleen, bone marrow, heart blood, or exudates) [2, 16]. Bacterial culture on blood agar or MacConkey agar yields characteristic small, non-hemolytic, Gram-negative coccobacilli after 24 h incubation at 37°C [32]. Confirmatory tests include biochemical profiling (oxidase positive, catalase positive, indole positive) and serotyping via capsular or somatic antigen detection.

Molecular diagnostics have enhanced detection sensitivity and speed. Polymerase chain reaction (PCR) assays targeting the kmc1 gene or capsular biosynthesis genes (e.g., hyaD-hyaC for capsular type A) are widely used [2, 8]. Real-time PCR can simultaneously detect and quantify P. multivocida in clinical specimens, including from live birds via oropharyngeal or cloacal swabs [7, 2]. In a study on Amsterdam Island, PCR detected P. multivocida in live Indian Yellow-nosed Albatrosses, Sooty Albatrosses, and Northern Rockhopper Penguins, confirming subclinical carriage [2].

Serological assays, including enzyme-linked immunosorbent assays (ELISA) using whole-cell or outer membrane protein antigens, are used for monitoring exposure and vaccine responses [17, 18]. A killed vaccine derived from a local strain allowed monitoring of antibody levels in albatross chicks and demonstrated 100% seroconversion post-vaccination [18].

flowchart TD
    A[Dead or sick bird], > B[Post-mortem examination]
    B, > C[Collect liver, spleen, heart blood, exudates]
    C, > D[Bacterial culture on blood agar]
    D, > E[Gram-negative coccobacilli]
    E, > F[Biochemical confirmation (oxidase, catalase, indole)]
    F, > G[Molecular PCR: kmc1 or capsular typing]
    G, > H[Serotyping: capsular/somatic]
    F, > I[Antimicrobial susceptibility testing]
    I, > J[Treatment decision]

Figure 1. Diagnostic workflow for avian cholera in suspect cases.

Treatment and Antimicrobial Resistance

Antimicrobial therapy is often employed in captive flocks to reduce mortality, but treatment success depends on early detection and antibiotic susceptibility of the isolate [4, 16]. P. multocida is typically susceptible to penicillins, tetracyclines, and fluoroquinolones, but resistance has been documented [4]. In two outbreaks in canaries in Brazil, the causative strains were resistant to sulfonamide, oxytetracycline, and enrofloxacin, but susceptible to amoxicillin; treatment with amoxicillin over three weeks controlled the outbreaks [4]. Similarly, in ring-necked pheasants, antibiotic therapy (likely tetracycline) successfully curtailed an outbreak, though continued surveillance is needed [16].

The use of plant extracts as alternatives to conventional antibiotics has been explored. Hydroacetone extracts of Solanum incanum (Solanaceae) showed antibacterial activity against P. multivocida in vitro, attributed to tannins and coumarins [19]. Cuminum cyminum extract also demonstrated activity against avian cholera in chicken embryo models [20]. Such phytotherapeutics may offer future options, especially in regions with limited access to veterinary drugs [19].

Control and Vaccination

Prevention of avian cholera relies on stringent biosecurity, sanitation, and vaccination where applicable. In poultry operations, management measures include all-in-all-out stocking, disinfection of premises, control of rodent and wild bird access, and prompt removal of dead birds [32]. For wild bird populations, limiting congregation at feeding sites and removing carcasses during outbreaks can reduce transmission [9].

Vaccination is a cornerstone of fowl cholera control in endemic areas. Both killed (bacterins) and live attenuated vaccines are available [21, 32]. Killed vaccines, often adjuvanted with aluminum hydroxide or propolis, induce humoral immunity and reduce mortality [21]. A study comparing propolis-adjuvanted versus aluminum hydroxide-adjuvanted inactivated vaccines found that the propolis formulation elicited a stronger immune response in chickens [21]. For endangered seabirds, a tailored killed vaccine using a local P. multivocida isolate successfully protected albatross chicks, increasing fledging probability from 14% to 46% [18]. This demonstrates that species-specific vaccines can be a critical conservation tool.

Herd immunity plays a profound role in outbreak fadeout. In Northern Common Eiders at Mitivik Island, annual antibody titers to P. multivocida in both sexes were inversely correlated with the real-time reproductive number (R_t) of the pathogen, indicating that acquired immunity drives epidemic fadeout [17]. This natural immunity can protect populations even in the absence of vaccination, but its duration and effectiveness vary.

Herd Immunity and Outbreak Dynamics

The dynamics of avian cholera in wildlife populations are heavily influenced by host immunity and environmental factors. In Arctic-nesting eiders, annual epidemics have shown wide variation in mortality, with an R_t above 1 in outbreak years and below 1 in fadeout years [17, 22]. Colony size and density also predict outbreak risk: larger colonies with more breeding females and higher crowding in shared wetlands are more likely to experience outbreaks [12]. Handling stress during field research has been shown to increase mortality in eiders during outbreak periods, suggesting that physiological stress exacerbates infection [23].

Mathematical modeling has demonstrated that avian cholera can lead to colony extinction if adult female mortality exceeds 30% in more than one outbreak per decade [3]. In a Danish eider colony, survival rates were significantly reduced during outbreak years, with a negative impact on population growth [24]. On Amsterdam Island, recurrent outbreaks have caused dramatic declines in Indian Yellow-nosed Albatrosses, Sooty Albatrosses, and Northern Rockhopper Penguins, and are a primary threat to the critically endangered Amsterdam Albatross (Diomedea amsterdamensis) [2].

Conservation Implications

Avian cholera is a major conservation concern for seabird populations worldwide. Outbreaks in penguin mega-colonies in Antarctica have been documented, with mass mortality events confounded by concurrent H5N1 highly pathogenic avian influenza surveillance [5]. In New Zealand, Yellow-eyed Penguins succumbed to P. multivocida infections, leading to significant mortality in a rapidly declining species [14]. At Amsterdam Island, the bacterium has been causing epizootics for over 30 years, and the demographic situation has worsened, with extremely low reproductive success in affected species [2].

Surveillance in remote regions often relies on community-based and traditional knowledge. Inuit hunters were the first to detect avian cholera outbreaks among Common Eiders in the eastern Canadian Arctic in 2004 [25, 26]. Their observations of sick and dead birds at sea and on small nesting islands allowed biologists to target investigations [25]. Such participatory surveillance is crucial for early detection and response, especially in areas with limited access [12]. The use of local ecological knowledge, combined with modern diagnostic tools, enhances the capacity to monitor disease spread and predict transmission risk [12, 26].

Conclusion

Avian cholera, caused by Pasteurella multocida, remains a significant threat to both domestic and wild avian populations. The bacterium’s ability to switch between acute and chronic forms, its environmental persistence, and its broad host range make control challenging. Advances in molecular diagnostics, vaccine development (including tailored vaccines for endangered species), and understanding of herd immunity are offering new avenues for management. Integrating surveillance with community knowledge and modeling population impacts will be essential to mitigate the effects of this disease on avian biodiversity and poultry production.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

References

[1] Botzler, R. EPIZOOTIOLOGY OF AVIAN CHOLERA IN WILDFOWL. Journal of Wildlife Diseases, 1991. [URL](https://www.semanticscholar.org/paper/08255de7a079

[2] Jaeger, A., Lebarbenchon, C., Bourret, V. et al. Avian cholera outbreaks threaten seabird species on Amsterdam Island. PLoS ONE, 2018. URL

[3] Descamps, S., Jenouvrier, S., Gilchrist, H. et al. Avian Cholera, a Threat to the Viability of an Arctic Seabird Colony? PLoS ONE, 2012. URL

[4] Marietto-Gonçalves, G. A., Tonin, A. A. AVIAN CHOLERA IN CANARIES (SERINUS CANARIA): REVIEW OF 2 OUTBREAKS. Journal of Exotic Pet Medicine, 2018. URL

[5] Iervolino, M., Günther, A., Schuele, L. et al. Mass mortality at penguin mega-colonies due to avian cholera confounds H5N1 HPAIV surveillance in Antarctica. bioRxiv, 2025. URL

[6] Wray, A. K., Bell, D., Dramer, P. et al. Waterbird Susceptibility to Avian Cholera at Hayward Marsh, California, USA. Journal of Wildlife Diseases, 2016. URL

[7] Dassanayake, R., Briggs, R. E., Kaplan, B. et al. Pasteurella multocida filamentous hemagglutinin B1 (fhaB1) gene is not involved with avian fowl cholera pathogenesis in turkey poults. BMC Veterinary Research, 2025. URL

[8] Petruzzi, B., Dalloul, R., LeRoith, T. et al. Biofilm formation and avian immune response following experimental acute and chronic avian cholera due to Pasteurella multocida. Veterinary Microbiology, 2018. URL

[9] Wille, M., McBurney, S., Robertson, G. et al. A PELAGIC OUTBREAK OF AVIAN CHOLERA IN NORTH AMERICAN GULLS: SCAVENGING AS A PRIMARY MECHANISM FOR TRANSMISSION? Journal of Wildlife Diseases, 2016. URL

[10] Hunter, B., Wobeser, G. Pathology of Experimental Avian Cholera. Journal of Wildlife Diseases, 2016. URL

[11] Hunter, B., Wobeser, G. Pathology of experimental avian cholera in mallard ducks. Avian Diseases, 1980. URL

[12] Iverson, S., Forbes, M., Simard, M. et al. Avian Cholera emergence in Arctic-nesting northern Common Eiders: using community-based, participatory surveillance to delineate disease outbreak patterns and predict transmission risk. Journal of Wildlife Diseases, 2016. URL

[13] Qin, H., Xiao, J., Li, J. et al. Climate Variability and Avian Cholera Transmission in Guangxi, China. Journal of Wildlife Diseases, 2017. URL

[14] Taylor, H., Foxwell, J., Jáuregui, R. et al. Pasteurella multocida Infections in Yellow-eyed Penguins (Hoiho; Megadyptes antipodes) in Otago, New Zealand: Case Series of Mortalities due to Avian Cholera. Journal of Wildlife Diseases, 2025. URL

[15] Bodenstein, B., Beckmen, K., Sheffield, G. et al. Avian Cholera Causes Marine Bird Mortality in the Bering Sea of Alaska. Journal of Wildlife Diseases, 2015. URL

[16] Brown, J. D., Dunn, P., Wallner-Pendleton, E. et al. Surveillance for Pasteurella multocida in Ring-Necked Pheasants (Phasianus colchicus) After an Outbreak of Avian Cholera and Apparently Successful Antibiotic Treatment. Avian Diseases, 2016. URL

[17] van Dijk, J. G. B., Iverson, S., Gilchrist, H. et al. Herd immunity drives the epidemic fadeout of avian cholera in Arctic-nesting seabirds. Scientific Reports, 2021. URL

[18] Bourret, V., Gamble, A., Tornos, J. et al. Vaccination protects endangered albatross chicks against avian cholera. Journal of Wildlife Diseases, 2018. URL

[19] Séré, M., Konaté, K., Santara, B. et al. Study of the antibacterial capacity of extracts of Solanum incanum L., (Solanaceae) traditionally used for the management of avian cholera in rural areas of Burkina Faso. World Journal of Advanced Research and Reviews, 2022. URL

[20] Al-Harbi, F. K. Antimicrobial activity of Cuminumcyminum extract against avian cholera in chicken embryo. International Journal of Research in Pharmaceutical Sciences, 2019. URL

[21] Tan, Y. Comparison Experiment of Immune Effect between Avian Cholera Propolis Adjuvant Inactivated Vaccine and Aluminum Hydroxide Gel Inactivated Vaccine. Journal of Veterinary Science and Technology, 2012. URL

[22] Iverson, S. A., Gilchrist, H. G., Soos, C. et al. Injecting epidemiology into population viability analysis: avian cholera transmission dynamics at an arctic seabird colony. Journal of Animal Ecology, 2016. URL

[23] Buttler, E. I., Gilchrist, H. G., Descamps, S. et al. Handling Stress of Female Common Eiders During Avian Cholera Outbreaks. Journal of Wildlife Diseases, 2011. URL

[24] Tjørnløv, R. S., Humaidan, J., Frederiksen, M. Impacts of avian cholera on survival of Common Eiders Somateria mollissima in a Danish colony. Journal of Wildlife Diseases, 2013. URL

[25] Henri, D., Jean-Gagnon, F., Gilchrist, H. Using Inuit traditional ecological knowledge for detecting and monitoring avian cholera among Common Eiders in the eastern Canadian Arctic. Journal of Wildlife Diseases, 2018. URL

[26] Harms, N. J. Dynamics of disease: origins and ecology of avian cholera in the eastern Canadian arctic. Journal of Wildlife Diseases, 2015. URL

[27] Gamble, A., Garnier, R., Jaeger, A. et al. Exposure of breeding albatrosses to the agent of avian cholera: dynamics of antibody levels and ecological implications. Oecologia, 2019. URL

[28] Iverson, S. Quantifying the demographic and population impact of avian cholera on northern common eiders in the face of ancillary threats and changing environmental circumstances. Journal of Wildlife Diseases, 2015. URL

[29] Descamps, S., Forbes, M., Gilchrist, H. et al. Avian cholera, post-hatching survival and selection on hatch characteristics in a long-lived bird, the common eider Somateria mollisima. Journal of Wildlife Diseases, 2011. URL